Relpax and Multiple sclerosis aggravated - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis aggravated is reported as a side effect among people who take Relpax (eletriptan hydrobromide), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Imitrex, and have Headache.

The phase IV clinical study analyzes which people have Multiple sclerosis aggravated when taking Relpax. It is created by eHealthMe based on reports of 8,715 people who have side effects when taking Relpax from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Multiple sclerosis aggravated?

Multiple sclerosis aggravated (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,020 drugs and 322 conditions by eHealthMe. Check the latest studies of Multiple sclerosis aggravated.

On Jul, 10, 2026

8,715 people reported to have side effects when taking Relpax.
Among them, 35 people (0.4%) have Multiple sclerosis aggravated.

Could Relpax cause Multiple sclerosis aggravated?

Among these 35 people:

How long have people been on Relpax when they have Multiple sclerosis aggravated? *

What is the gender of people who have Multiple sclerosis aggravated when taking Relpax? *

female: 78.79 %
male: 21.21 %

What is the age of people who have Multiple sclerosis aggravated when taking Relpax? *

What are other drugs people take besides Relpax? *

What are other side effects people have besides Multiple sclerosis aggravated? *

Chest Pain: 10 people, 28.57%
Drug Ineffective: 8 people, 22.86%
Headache (pain in head): 6 people, 17.14%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 14.29%
Pain In Extremity: 4 people, 11.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 8.57%
Gait Disturbance: 3 people, 8.57%
Fatigue (feeling of tiredness): 3 people, 8.57%
Fall: 3 people, 8.57%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 3 people, 8.57%

What are the existing conditions these people have? *

Headache (pain in head): 8 people, 22.86%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 14.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 14.29%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 4 people, 11.43%
Pain: 3 people, 8.57%
Pain In Extremity: 2 people, 5.71%
Osteoporosis (bones weak and more likely to break): 2 people, 5.71%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 5.71%
Muscle Aches (muscle pain): 2 people, 5.71%
Joint Pain: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and have Multiple sclerosis aggravated?

- Check whether Multiple sclerosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Relpax:

Relpax (9,259 reports)

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (1,020 drugs)

Browse all the conditions that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (322 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide (the active ingredients of Relpax) and Relpax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.